advisorsecurities master

CRVOCervoMed Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
13813
Ticker
CRVO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1996-06-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CRVO

Detail

Enriched 2026-08-14 20:47

Market cap
$41,525,535.31
Shares outstanding (class)
13,526,233
Shares outstanding (weighted)
13,526,233
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
15
Location
BOSTON, MA
Description

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data